Brigitte Widemann Selected Research

Brigitte Widemann Research Topics

3	Neoplasms (Cancer) 04/2012 - 09/2010
2	Thyroid Neoplasms (Thyroid Cancer) 01/2015 - 02/2012
1	Hypothyroidism 01/2015
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 01/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2013
1	Burkitt Lymphoma (Burkitt's Lymphoma) 11/2013
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2013
1	Neurofibroma 01/2013
1	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 01/2013
1	Neurofibromatoses (Neurofibromatosis) 01/2013
1	Cryopyrin-Associated Periodic Syndromes 07/2012
1	Inflammation 07/2012
1	Prostatic Neoplasms (Prostate Cancer) 04/2012
1	Hyperbilirubinemia 04/2012
1	Neoplasm Metastasis (Metastasis) 02/2012
1	Neuroblastoma 09/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2005
1	Basal Cell Neoplasms (Basal Cell Cancer) 05/2003
1	Neutropenia 05/2003

1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2015
1	HormonesIBA 01/2015
1	N- (4- bromo- 2- fluorophenyl)- 6- methoxy- 7- ((1- methylpiperidin- 4- yl)methoxy)quinazolin- 4- amine (ZD6474)IBA 01/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2013
1	rituximab (Mabthera)FDA Link 11/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2013
1	Prednisone (Sone)FDA LinkGeneric 11/2013
1	Vincristine (Oncovin)FDA LinkGeneric 11/2013
1	Etoposide (VP 16)FDA LinkGeneric 11/2013
1	SchwannomatosisIBA 01/2013
1	PD 0325901IBA 01/2013
1	Interleukin-1 (Interleukin 1)IBA 07/2012
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2012
1	TransferasesIBA 04/2012
1	sorafenib (BAY 43-9006)FDA Link 04/2012
1	UridineIBA 04/2012
1	BilirubinIBA 04/2012
1	indium-111-octreotideIBA 02/2012
1	Somatostatin Receptors (Somatostatin Receptor)IBA 02/2012
1	ABT751IBA 09/2010
1	Methotrexate (Mexate)FDA LinkGeneric 04/2005
1	Filgrastim (Neupogen)FDA Link 05/2003
1	ixabepilone (BMS 247550)FDA Link 05/2003

2	Drug Therapy (Chemotherapy) 01/2015 - 11/2013
1	Thyroidectomy 01/2015
1	Heterologous Transplantation (Xenotransplantation) 01/2013